Citation Impact
Citing Papers
Morbidity and medication in a large population of individuals with Down syndrome compared to the general population
2015
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Electroencephalography.
1994
Workup and management of patients with syncope
1995
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
2015
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
2009 Standout
Advances in the Pharmacotherapy of Epilepsy
1993
Early Identification of Refractory Epilepsy
2000 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009
2010 Standout
Suicide as an outcome for mental disorders
1997 Standout
Comparison of rating scales for the diagnosis of dementia in adults with Down’s syndrome
1999
Consequences of antiepileptic drug withdrawal: A randomized, double‐blind study (Akershus Study)
2007
Glioblastoma and Other Malignant Gliomas
2013 Standout
Clinical, social, and ethical implications of changing life expectancy in Down syndrome
2004
Genetic and host factors for dementia in Down's syndrome
2002
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Adverse Drug Interactions in Anesthesia
1997
Selenium and human health
2012 Standout
A Probable Causative Factor for an Old Problem: Selenium and Glutathione Peroxidase Appear to Play Important Roles in Epilepsy Pathogenesis
2007
Clinically relevant drug interactions with antiepileptic drugs
2005
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Historical criteria that distinguish syncope from seizures
2002
Some Aspects of Prognosis in the Epilepsies: A Review
1993
Participation in online patient support groups endorses patients’ empowerment
2008
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
2006 Standout
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Pharmacokinetics of Haloperidol
1989
Fifteen‐year follow‐up of 92 hospitalized adults with Down’s syndrome: incidence of cognitive decline, its relationship to age and neuropathology
2007
Design of clinical antiepileptic drug trials
1995
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
2010
Innovative Designs of Controlled Clinical Trials in Epilepsy
1993
Social Media Use in the United States: Implications for Health Communication
2009 Standout
Down Syndrome: Advances in Molecular Biology and the Neurosciences
2001
Lamotrigine plasma levels reduced by oral contraceptives
2001
Pharmacological Modulation of Cortical Excitability Shifts Induced by Transcranial Direct Current Stimulation in Humans
2003 Standout
Epilepsy and quality of life in adults: A review of instruments
2005
Dementia in Down's syndrome
2016
Interplay between Cortical Spreading Depolarization and Seizures
2017 Standout
The four ages of Down syndrome
2006
The Effects of Phenytoin on Impulsive and Premeditated Aggression
1997
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Phenotype associated with APP duplication in five families
2006
Pharmacokinetics of Haloperidol
1999
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Belief, knowledge and expertise: the emergence of the lay expert in medical sociology
2003 Standout
Managing the care of adults with Down's syndrome
2014
Newer Anticonvulsants
2000
Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant
2000
Surgery for Seizures
1996 Standout
Clinical aspects and biological bases of drug-resistant epilepsies
1999
Cognitive Function in Preschool Children after Epilepsy Surgery: Rationale for Early Intervention
2005
Physical Activity and Public Health in Older Adults
2007 Standout
The Relative Contributions of MRI, SPECT, and PET Imaging in Epilepsy
1994
Down's syndrome
2003 Standout
Psychiatric Aspects of Impulsivity
2001 Standout
Epilepsy and cognition
2003
Incidence and Prognosis of Syncope
2002 Standout
Alzheimer disease and Down syndrome: factors in pathogenesis
2004
Herbal Medicines and Perioperative Care
2001 Standout
Spreading depression: a review of the clinical relevance
2001
Down syndrome
2020 Standout
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Guidelines on management (diagnosis and treatment) of syncope
2001
Multiple partial seizure-like symptoms following ‘minor’ closed head injury
1992 StandoutNobel
Mortality and morbidity among older adults with intellectual disability: health services considerations
1999
Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development
2007
Diagnostic criteria for vasovagal syncope based on a quantitative history
2005
Down Syndrome
2020 Standout
Dementia in Older Adults With Intellectual Disabilities-Epidemiology, Presentation, and Diagnosis
2010
Exercise and Physical Activity for Older Adults
2009 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Recognizing Syncope: Pitfalls and Surprises
1996
Flunarizine A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use
1984
Diabetic Neuropathies
2005 Standout
Social functioning and seizure status of young adults with onset of epilepsy in childhood.
1983
Clinical, social, and ethical implications of changing life expectancy in Down syndrome
2004
ILAE Official Report: A practical clinical definition of epilepsy
2014 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Calcium channels and calcium channel antagonists
1987
Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists
1975 StandoutNobel
Topiramate vs placebo in painful diabetic neuropathy
2004
Physical Activity and Public Health in Older Adults
2007 Standout
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
1998 Standout
CLINICAL GUIDELINE: Diagnosing Syncope: Part 2: Unexplained Syncope
1997
Functional connectivity in the resting brain: A network analysis of the default mode hypothesis
2002 Standout
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage
1988 Standout
Family caregivers of people with dementia
2009 Standout
SELECTIVE COGNITIVE IMPAIRMENT DURING FOCAL AND GENERALIZED EPILEPTIFORM EEG ACTIVITY
1984
Epileptic seizure disorders
1985
CLINICAL GUIDELINE: Diagnosing Syncope: Part 1: Value of History, Physical Examination, and Electrocardiography
1997
A cascade of disparities: Health and health care access for people with intellectual disabilities
2006 Standout
Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome
2018
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of J. Overweg being referenced
Neuropsychological Aspects of Learning Disabilities in Epilepsy
1990
Syncope or seizure? A matter of opinion
1992
Transient loss of consciousness: The value of the history for distinguishing seizure from syncope
1991
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy
1989
Use of electroencephalography to detect Alzheimer's disease in Down's syndrome
1996
Focus localization in patients with partial epilepsy with 99Tcm-HMPAO SPECT under continuous surface EEG monitoring
1992
Cognitive side-effects of phenytoin compared with carbamazepine in patients with localization-related epilepsy
1994
γ‐Vinyl GABA (Vigabatrin) and Mood Disturbances
1994
Clinical and EEG prediction of seizure recurrence following antiepileptic drug withdrawal
1987
Electroencephalographic findings in antiepileptic drug trials: a review and report of 6 studies
1987
A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset Seizures
2000
Telemetric EEG and video monitoring in epilepsy
1981
Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.
1997
Seizure Prognosis in Long‐Stay Mentally Subnormal Epileptic Patients: Interrater EEG and Clinical Studies
1980
Quality of Life in Epilepsy: Multidimensional Profile and Underlying Latent Dimensions
1998
Syncope or seizure? The diagnostic value of the EEG and hyperventilation test in transient loss of consciousness.
1991
Aura and post-ictal headache in epileptic patients treated with flunarizine.
1987
Cognitive effects of lamotrigine as first-line add-on in patients with localization-related (partial) epilepsy
1997
Acute Effects of Lamotrigine (BW430C) in Persons With Epilepsy
1986
Double‐Blind Placebo‐Controlled Trial of Flunarizine as Add‐on Therapy in Epilepsy
1984
Open Dose‐Ranging Trial of Flunarizine as Add‐On Therapy in Epilepsy
1985